Cellution Biologics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Cellution Biologics
Cellution Biologics Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 2020 (Four years and seven months 26 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Abhayakumar and Abhaya Mayur serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U33110TN2020PTC135621
- Company No.
135621
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2020
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Cellution Biologics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhaya Mayur  | Director | 09-Aug-2024 | Current |
| Deepak Abhayakumar | Director | 09-Aug-2024 | Current |
Financial Performance of Cellution Biologics.
Cellution Biologics Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cellution Biologics?
In 2021, Cellution Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
H S Pathology Private LimitedDeepak Abhayakumar and Abhaya Mayur are mutual person
Venkata Narayana Active Ingredients Private LimitedDeepak Abhayakumar is a mutual person
Novocura Tech Health Services Private LimitedAbhaya Mayur is a mutual person
Spovum Technologies Private LimitedAbhaya Mayur is a mutual person
Dhanvantari Nano Ayushadi Private LimitedDeepak Abhayakumar is a mutual person
Supath Healthcare Services Private LimitedAbhaya Mayur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cellution Biologics?
Cellution Biologics has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cellution Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cellution Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
